Archangels

Archangels, established in 1992, stands as a prominent business angel syndicate headquartered in Edinburgh, Scotland. With a deep-rooted commitment to fostering innovation within its home country, the syndicate primarily focuses its investments on early-stage technology and life sciences companies based in Scotland. Its long-standing presence in the Scottish investment landscape has positioned it as a key player in supporting the growth of promising startups and scale-ups, providing both crucial capital and strategic guidance.

The syndicate's investment strategy is characterized by its hands-on approach and a preference for co-investment. Archangels typically provides initial cheques ranging from £100,000 to £500,000, often participating as part of larger funding rounds that can total between £250,000 and £2 million. This collaborative model frequently sees them partnering with other angel groups, venture capital funds, and public sector bodies like Scottish Enterprise, leveraging collective expertise and capital to maximize portfolio company success.

Over its more than three decades of operation, Archangels has demonstrated a significant impact on the Scottish entrepreneurial ecosystem. The syndicate has invested over £150 million into Scottish companies since its inception, a testament to its sustained commitment to the region's economic development. This substantial capital has been deployed across more than 90 companies, reflecting a broad and diverse portfolio. Beyond financial backing, Archangels prides itself on offering mentorship and strategic support, helping founders navigate the challenges of early-stage growth and prepare for subsequent funding rounds. Their enduring mission is to identify, nurture, and scale high-potential Scottish businesses, contributing to job creation and technological advancement.